IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-LASource pending

Cleo Fields disclosed BUY $AAPL

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$15K – $50K
Filed
2025-07-02
Trade date
2025-06-30
Disclosure lag
2 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 2 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
443 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Cleo Fields, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 21 lobbying filings.

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-07-02 · disclosed 2d after transaction

Market context

Apple Inc.

Sector: Technology

Factual flags

  • 21 lobbying filings linked to this ticker.
  • 43 nearby same-ticker disclosures in the surrounding 30-day window.
  • Traded AAPL 21d before lobbying filing by APPLE INC ($2,290,000) (committee overlap: Financials)
  • 38 trades filed on 2025-07-02 (batch dump)

Member trail

Cleo Fields

U.S. House · LA-6

House Committee on Financial Services

Ticker trail

$AAPL

Apple Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.